Resveratrol and the NAD+ Debate That Started It All

Resveratrol, a compound found in red wine and grape skins, became famous after early 2000s research proposed it activated sirtuins, a family of proteins linked to caloric restriction's lifespan-extending effects in animal models, largely through interactions with NAD+ availability. The finding sparked enormous public and scientific interest, essentially launching the modern longevity supplement industry.

Subsequent research complicated the initial story considerably. Later studies questioned whether resveratrol directly activates sirtuins in the way first proposed, and human trials generally failed to replicate the dramatic lifespan or metabolic benefits seen in some early animal studies, partly due to resveratrol's notoriously poor bioavailability when taken orally. The compound remains an active area of research, but the scientific narrative around it has grown considerably more cautious than the marketing that followed its initial discovery.

Why this matters for tracking: resveratrol's history is a useful reminder of how a genuinely interesting mechanistic finding in animal models can outpace what human trials eventually support, a pattern longevity research keeps encountering.